Riverwater Partners’s CVS Health CVS Stock Holding History

Riverwater Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,390	Closed	-$268K	–	195
2023 Q4	$268K	Sell	3,390 -815	-19%	-$58K	0.21%	155
2023 Q3	$294K	Buy	4,205 +821	+24%	+$58.2K	0.27%	135
2023 Q2	$234K	Buy	3,384 +166	+5%	+$11.8K	0.21%	162
2023 Q1	$239K	Sell	3,218 -19	-0.6%	-$1.59K	0.22%	154
2022 Q4	$302K	Sell	3,237 -3	-0.1%	-$289	0.26%	127
2022 Q3	$309K	Sell	3,240 -13	-0.4%	-$1.29K	0.31%	107
2022 Q2	$301K	Buy	+3,253	New	+$317K	0.3%	118
2022 Q1	–	Sell	-3,257	Closed	-$336K	–	125
2021 Q4	$336K	Buy	+3,257	New	+$301K	0.3%	126

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Riverwater Partners's CVS Position: Q1 2024 in Review

Riverwater Partners sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,390 shares — an estimated $268K sold.

Riverwater Partners first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $336K in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Riverwater Partners reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
Riverwater Partners sold 3,390 CVS Health shares in Q1 2024, an estimated $268K.
Riverwater Partners first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
Riverwater Partners's CVS Health position peaked at $336K in Q4 2021.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Riverwater Partners's 13F filing for Q1 2024, filed 19 Apr 2024.